References
Jennings RB, Reimer KA. Lethal myocardial ischemic injury. Am J Pathol 1981;102:241–55.
Jennings RB, Sommers HM, Kaltenbach JP, West JJ. Electrolyte alterations in acute myocardial ischemic injury. Circ Res 1964;14:260–9.
Bottomley PA. Noninvasive study of high-energy phosphate metabolism in human heart by depth-resolved 31P NMR spectroscopy. Science 1985;229:769–72.
Weiss RG, Bottomley PA, Hardy CJ, Geisteath, G.. Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary area disease. New Engl J Med 1990;323:1593–600.
Yabe T, Mitsunami K, Okada M, Monkara S, Inubushi T, Kinoshita M. Detection of myocardial ischemic by 31P magnetic resonance spectroscopy during handgrip exercise. Circulation 1994;89:1709–16.
Neubauer S, Krahe T, Schindler R, Horn M, Hillenbrand H, Entzeroth C, Mader H, Kromer EP, Riegger GAJ, Lackner K, Ertl G. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Circulation 1992;86:1810–8.
Bottomley PA, Atalar E, Weiss RG. Human cardiac high-energy phosphate metabolite concentrations by ID-resolved NMR spectroscopy. Magn Reson Med 1995;35:664–70.
Bottomley PA, Weiss RG. Noninvasive MRS detection of localized creatine depletion in non-viable, infarcted myocardium. The Lancet 1998;351:714–8.
Bottomley PA, Weiss RG. Reductions in creatine kinase metabolite concentrations in infarcted myocardium by noninvasive MRS. Proc ISMRM 1997;1:480.
Yabe T, Mitsunami K, Inubushi T, Kinoshita M. Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31P magnetic resonance spectroscopy. Circulation 1995;92:15–23.
Bottomley PA, Hardy CJ. Mapping creatine kinase reaction rates in human brain and heart with 4 Tesla saturation transfer 31P NMR. J Magn Reson 1992;99:443–8.
Ouwerkerk R, Lee R, Weiss RG, Bottomley P. A new FAST method for in vivo measurement of chemical exchange rates. Proc Int Soc Magn Reson Med 2000;1:421.
Ra JB, Hilal SK, Oh CH, Mun IK. In vivo magnetic resonance imaging of sodium in the human body. Magn Reson Med 1988;7:11–22.
Kim RJ, Lima JOAC, Chen EL, Reeder SB, Klocke FJ, Zerhouni EA, Judd RM. Fast 23Na magnetic resonance imaging of acute reperfused myocardial infarction. Potential to assess myocardial viability. Circulation 1997;95:1877–85.
Constantinides CD, Weiss RG, Lee R, Bolar D, Bottomley PA. Restoration of low resolution metabolic images with a priori anatomic information: 23Na MRI in myocardial infarction. Magn Reson Imag 2000;18:461–71.
Lee RF, Giaquinto R, Constantinides CD, Souza S, Weiss RG, Bottomley PA. A broadband phased-array system for direct phosphorus and sodium metabolic MRI on a clinical scanner. Magn Reson Med 2000;43:269–77.
Constantinides CD, Gillen JS, Boada FE, Pomper MG, Bottomley PA. Human skeletal muscle: 23Na MR imaging and quantification-potential applications in exercise and disease. Radiology 2000;216:559–68.
Constantinides CD, Kraitchman D, O’Brien K, Boada F, Gillen J, Bottomley PA. Noninvasive quantification of total sodium concentrations in myocardial infarction using 23Na MRI. Proc Int Soc Magn Reson Med 2000;1:130.
Ouwerkerk R, Lee RF, Bottomley PA. Dynamic changes in sodium levels in human exercising muscle measured with 23Na MRI. Proc Intl Soc Mag Reson Med 1999;3:1530.
Bottomley PA, Hardy CJ. Proton Overhauser enhancements in human cardiac phosphorus NMR spectroscopy at 1.5-T. Magn Reson Med 1992;24:384–90.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bottomley, P.A., Lee, R.F., Constantinides, C.D. et al. Quantification and imaging of myocardial sodium and creatine kinase metabolites. MAGMA 11, 39–41 (2000). https://doi.org/10.1007/BF02678489
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02678489